
Validea's guru fundamental report highly rates Mastercard (MA) at 86% using its Warren Buffett-inspired 'Patient Investor' model, indicating strong alignment with criteria for predictable profitability, low debt, and reasonable valuation within the Consumer Financial Services sector. While MA passes key fundamental tests such as earnings predictability, return on equity, and free cash flow, it notably fails the 'Initial Rate of Return' criterion, suggesting it aligns more as a quality growth investment rather than a deep value opportunity.
Mastercard Inc. (MA) scores an 86% rating from Validea's 'Patient Investor' model, which emulates Warren Buffett's investment criteria, indicating a strong alignment with principles of long-term, predictable profitability. The analysis highlights MA's robust fundamentals, as it passes key tests for Earnings Predictability, Return on Equity, Return on Assets, and Free Cash Flow generation. Furthermore, the company receives a passing grade for its Use of Retained Earnings and Share Repurchase program, signaling effective capital management and a commitment to returning value to shareholders. The single point of failure is on the 'Initial Rate of Return' criterion, which suggests that while the company's quality is high, its current valuation may not offer the significant discount a classic value investor would seek. This positions MA not as a deep value opportunity, but as a high-quality compounder whose strong fundamentals are already reflected in its market price.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment